StemCell Therapy

The Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Our analysts monitoring the situation around the Globe explain that after COVID-19 crisis the market will generate remunerative prospects for producers. The goal of the report is to provide a further illustration of the current scenario, economic slowdown and effect of COVID-19 on the industry as a whole.

Biomarkers Market was valued at USD 36.3 Billion in 2018 and expected to reach USD 91.4 Billion by 2025 with a CAGR of 14.1% during the forecast period. Increasing prevalence of cancer and growing precision medicine market are amongst the pivotal factors anticipated to spur the growth of Biomarkers Market.

The global biomarkers market is witnessing a healthy growth trajectory attributed to the growing application of biomarkers in diagnostics, increasing funding for biomarkers research, as well as its rising usage in drug discovery. Biomarkers are biological molecules found in body fluids and tissues that help in crucial clinical decision making and diagnosing various health conditions of the patients. Since the molecules can analyze pharmacological responses and pathological indications, they can effectively assist in process of drug discovery and development.

The diagnostics industry has been witnessing a shift in trend from using conventional diagnostic tools towards using more advanced diagnostic methods that focus on producing accurate and consistent results during early stage of diseases. This has led to boost in demand for biomarkers which are minimally or non-invasive tools to detect diseases such as cancer at early stage. Moreover, growing usage of precision medicine should further boost the biomarkers market growth.

Apart from this, expediting growth in the healthcare IT industry and low costs of clinical trials in emerging countries has favored the entry of various new players in the market. A large chunk of funding is being invested in research and development for new product launches. For instance, in March 2018, Genomic Health, Inc. launched the Oncotype DX AR-V7 Nucleus Detect test. The AR-V7 protein is a prognostic and predictive biomarker. This test aids physicians in taking therapeutic decisions in patients suffering from metastatic castration-resistant prostate cancer (mCRPC) by accurately detecting a splice variant of the androgen receptor protein (AR-V7) in the nucleus of circulating tumor cells (CTCs).

Recent Developments In May 2019, Qiagen announced the immediate launch of its first companion diagnostics assay therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) post U.S. FDA regulatory approval as a companion diagnostic to assist in diagnosing breast cancer patients that would be eligible for treatment with newly approved therapy PIQRAY (alpelisib) developed and marketed by Novartis.

Key Players in Biomarkers Market Some of the major players operating in the Global Biomarkers Market include Siemens Healthineers, Medtronic, F. Hoffman LA Roche Ltd., Abbott Laboratories Nexus-DX, Qiagen N.V., PerkinElmer, Inc., Lifesign LLC., Merck & Co, Inc., Bio-Rad Laboratories, EKF Diagnostics Holdings plc, Singulex, Inc., Signosis, Inc, and BioSims Technologies among others.

Global Biomarkers market is segmented on the basis of product, type, application, and disease indication. The Global Biomarkers Market by product includes consumables, services, and software, while based on type the industry is segmented into safety, efficacy, and validation. By application market segmentation includes diagnostics, drug development, personalized medicine, and disease risk assessment. Biomarkers market by disease indication comprises of cancer, cardiovascular diseases, neurological diseases, immunological diseases, and others.

Increasing incidence of cancer and growing precision medicine market are some of the pivotal factors boosting the Biomarkers market growth. Increasing incidence of cancer is one of the pivotal factors which is set to drive the growth of Biomarkers Market. According to World Health Organization (WHO) statistics, various types of cancer accounted for more than 9.5 million deaths in 2018 worldwide. Cancer biomarkers are released by cancer causing tumors that can be detected in blood stream and other tissues, thus helping in early clinical evaluation and deciding the course of treatment.

Moreover, the World Health Assembly has passed the resolution in 2017 for Cancer Prevention and Control. This integrated approach (WHA70.12) has recommended the governments and WHO to speed up action plans specified in the Global Action Plan and 2030 UN Agenda for Sustainable Development to reduce premature mortality from cancer. This has led to a boost in demand for early cancer screening tests and procedures. Increasing focus of research institutes to develop such biomarkers is likely to spur the global Biomarkers Market growth.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Biomarkers Market.

Key Benefits for Biomarkers Market Reports Global market report covers in-depth historical and forecast analysis. Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. Global market report helps to identify opportunities in market place. Global market report covers extensive analysis of emerging trends and competitive landscape.

By Product:ConsumablesServicesSoftware

By Type: SafetyEfficacyValidation

By Application:DiagnosticsDrug DevelopmentPersonalized MedicineDisease Risk Assessment

By Disease Indication:CancerCardiovascular DiseasesNeurological DiseasesImmunological DiseasesOthers

By Region North Americao U.S.o Canadao Mexico Europeo UKo Franceo Germanyo Russiao Rest of Europe Asia-Pacifico Chinao South Koreao Indiao Japano Rest of Asia-Pacific LAMEAo Latin Americao Middle Easto Africa

North America grabbed the largest share in Biomarkers Market globally In 2018, North America accounted for the largest share in the global biomarkers market owing to increasing adoption of precision medicine and rising prevalence of cancer in the region. The largest share of the region is also attributed to the rise in number of cancer cases in the U.S. and launch of Precision Medicine Initiative (PMI) by the U.S. government in 2015. According to the National Cancer Institute statistics, more than 16.5 million cases of cancer were diagnosed in 2016 in the U.S, and this number is expected to reach to 19 million in 2024.

The increasing application of biomarkers in the field of precision medicine should also drive the market in this region. Identification of biomarkers is essential for the development of precision medicine. The U.S. precision medicine industry has been booming post the launch of Precision Medicine Initiative by the government in 2015. The initiative aimed at improving the treatment outcome by offering tailor made therapies to patients. This has spurred the development of novel treatments and drugs based on an individuals genetic profile and characteristics of tumor. The Asia Pacific Biomarkers market is set to showcase lucrative growth in the coming years due to vast patient pool, increasing awareness regarding early disease detection and rising healthcare expenditure in the emerging countries of India and China.

Biomarkers Market Key Players: Siemens Healthineers Medtronic F. Hoffman LA Roche Ltd. Abbott Laboratories Nexus-DX Qiagen N.V. PerkinElmer, Inc. Lifesign LLC. Merck & Co, Inc. Bio-Rad Laboratories EKF Diagnostics Holdings plc Others

This comprehensive report will provide: Enhance your strategic decision making Assist with your research, presentations and business plans Show which emerging market opportunities to focus on Increase your industry knowledge Keep you up-to-date with crucial market developments Allow you to develop informed growth strategies Build your technical insight Illustrate trends to exploit Strengthen your analysis of competitors Provide risk analysis, helping you avoid the pitfalls other companies could make Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question: Which are the driving factors responsible for the growth of market? Which are the roadblock factors of this market? What are the new opportunities, by which market will grow in coming years? What are the trends of this market? Which are main factors responsible for new product launch? How big is the global & regional market in terms of revenue, sales and production? How far will the market grow in forecast period in terms of revenue, sales and production? Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? Which region has more opportunities?

Table of Content1 Study Coverage1.1 Biomarkers Product1.2 Key Market Segments in This Study1.3 Key Manufacturers Covered1.4 Market by Type1.5 Market by Application1.6 Study Objectives1.7 Years Considered

2 Executive Summary2.1 Global Biomarkers Market Size2.1.1 Global Biomarkers Revenue 2014-20252.1.2 Global Biomarkers Production 2014-20252.2 Biomarkers Growth Rate (CAGR) 2020-20252.3 Analysis of Competitive Landscape2.3.1 Manufacturers Market Concentration Ratio2.3.2 Key Biomarkers Manufacturers2.3.2.1 Biomarkers Manufacturing Base Distribution, Headquarters2.3.2.2 Manufacturers Biomarkers Product Offered2.3.2.3 Date of Manufacturers Enter into Biomarkers Market2.4 Key Trends for Biomarkers Markets & Products

3 Market Size by Manufacturers3.1 Biomarkers Production by Manufacturers3.1.1 Biomarkers Production by Manufacturers3.1.2 Biomarkers Production Market Share by Manufacturers3.2 Biomarkers Revenue by Manufacturers3.2.1 Biomarkers Revenue by Manufacturers (2014-2020)3.2.2 Biomarkers Revenue Share by Manufacturers (2014-2020)3.3 Biomarkers Price by Manufacturers3.4 Mergers & Acquisitions, Expansion Plans

4 Biomarkers Production by Regions4.1 Global Biomarkers Production by Regions4.1.1 Global Biomarkers Production Market Share by Regions4.1.2 Global Biomarkers Revenue Market Share by Regions4.2 North America4.2.1 North America Biomarkers Production4.2.2 North America Biomarkers Revenue4.2.3 Key Players in North America4.2.4 North America Biomarkers Import & Export4.3 Europe4.3.1 Europe Biomarkers Production4.3.2 Europe Biomarkers Revenue4.3.3 Key Players in Europe4.3.4 Europe Biomarkers Import & Export4.4 China4.4.1 China Biomarkers Production4.4.2 China Biomarkers Revenue4.4.3 Key Players in China4.4.4 China Biomarkers Import & Export4.5 Japan4.5.1 Japan Biomarkers Production4.5.2 Japan Biomarkers Revenue4.5.3 Key Players in Japan4.5.4 Japan Biomarkers Import & Export

5 Biomarkers Consumption by Regions5.1 Global Biomarkers Consumption by Regions5.1.1 Global Biomarkers Consumption by Regions5.1.2 Global Biomarkers Consumption Market Share by Regions5.2 North America5.2.1 North America Biomarkers Consumption by Application5.2.2 North America Biomarkers Consumption by Countries5.2.3 United States5.2.4 Canada5.2.5 Mexico5.3 Europe5.3.1 Europe Biomarkers Consumption by Application5.3.2 Europe Biomarkers Consumption by Countries5.3.3 Germany5.3.4 France5.3.5 UK5.3.6 Italy5.3.7 Russia5.4 Asia Pacific5.4.1 Asia Pacific Biomarkers Consumption by Application5.4.2 Asia Pacific Biomarkers Consumption by Regions5.4.3 China5.4.4 Japan5.4.5 South Korea5.4.6 India5.4.7 Australia5.4.8 Indonesia5.4.9 Thailand5.4.10 Malaysia5.4.11 Philippines

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [emailprotected]

Blog: https://businessstatsnews.com

Blog: http://www.dailyindustrywatch.com

Blog: https://marketsize.biz

Blog: https://technologyindustrynews.com

Blog: https://marketstatsreport.com

Top Trending Reports:

https://www.marketwatch.com/press-release/tart-cherry-market-size-share-from-2020-to-2025-growth-forecast-analysis-by-manufacturers-type-and-application-2020-08-13?tesla=y

https://www.marketwatch.com/press-release/global-gaming-hardware-market-2020-industry-analysis-by-share-trends-growth-factors-cagr-status-growth-opportunities-segmentation-and-forecast-2025-2020-08-13?tesla=y

https://www.marketwatch.com/press-release/obsessive-compulsive-disorder-ocd-market-2020-growth-analysis-share-demand-types-top-key-players-and-forecast-to-2025-2020-08-13?tesla=y

https://www.marketwatch.com/press-release/geocells-market-size-revenue-analysis-growth-opportunities-and-forecast-2025-strata-systems-inc-wrekin-products-ltd-armtec-infrastructure-inc-maccaferri-spa-ace-2020-08-13?tesla=y

https://www.marketwatch.com/press-release/at-1150-cagr-biophotonics-market-size-to-surpass-usd-8908-billion-by-2025-forecast-by-applications-dynamics-development-status-and-outlook-2025-2020-08-13?tesla=y

Read the original here:
Outlook on the Worldwide Biomarkers Industry to 2025 Scientect - Scientect

This entry was posted on August 15, 2020 at 9:49 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |